GLSI
4:30 PM
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-Q Filing
greenwichlifesciences.com
News Updates
Fri, May 22, 2026
1 updatesThu, Apr 30, 2026
1 updatesGLSI
6:00 AM
Greenwich LifeSciences Provides Update Regarding Form 10-K Filing
Interim Data • Phase 3greenwichlifesciences.com
Thu, Apr 23, 2026
1 updatesGLSI
6:00 AM
Greenwich LifeSciences Announces Acceptance of Abstract at ASCO 2026
Presentation / Abstract • Phase 3greenwichlifesciences.com
Wed, Apr 22, 2026
1 updatesGLSI
5:00 PM
Greenwich LifeSciences Announces Receipt of Nasdaq Notice Regarding Late Form 10-K Filing
greenwichlifesciences.com
Mon, Apr 20, 2026
1 updatesGLSI
6:00 AM
Greenwich LifeSciences Presents FLAMINGO-01 Phase III Trial Open Label Data Published at AACR Meeting 2026
Presentation / Abstract • Phase 3greenwichlifesciences.com
Tue, Apr 14, 2026
1 updatesGLSI
6:00 AM
Greenwich LifeSciences Provides Update on Financing Strategy
greenwichlifesciences.com
Tue, Apr 7, 2026
1 updatesGLSI
6:00 AM
Greenwich LifeSciences Provides Update on Patent Claims Potentially Doubling GP2 Market Potential
greenwichlifesciences.com
Thu, Mar 19, 2026
1 updatesGLSI
6:00 AM
Greenwich LifeSciences Announces Addition of City of Hope to FLAMINGO-01
greenwichlifesciences.com
Wed, Mar 18, 2026
1 updatesGLSI
6:00 AM
Greenwich LifeSciences Provides Update on Upcoming AACR Meeting
Presentation / Abstract • Phase 3greenwichlifesciences.com
Tue, Mar 17, 2026
1 updatesGLSI
6:00 AM
Greenwich LifeSciences Provides Update Showing Continued Reduction in Recurrence Rate in the Open Label Arm of FLAMINGO-01
Interim Data • Phase 3greenwichlifesciences.com
Mon, Mar 16, 2026
1 updatesGLSI
6:00 AM
Greenwich LifeSciences Announces Use of Commercially Manufactured GP2 in FLAMINGO-01
greenwichlifesciences.com
Tue, Mar 3, 2026
1 updatesGLSI
6:00 AM
Greenwich LifeSciences Provides Update on Increased Patient Screen Rate in FLAMINGO-01
greenwichlifesciences.com